Acura Pharmaceuticals, Inc. (ACUR)

OTCMKTS: ACUR · Delayed Price · USD
0.480
0.000 (0.00%)
Jun 29, 2022 4:00 PM - Market closed
0.00%
Market Cap 31.24M
Revenue (ttm) 2.25M
Net Income (ttm) -908,243
Shares Out 65.09M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 46
Open 0.350
Previous Close 0.480
Day's Range 0.480 - 0.480
52-Week Range 0.290 - 0.740
Beta 0.44
Analysts Buy
Price Target n/a
Earnings Date Jul 4, 2022

About ACUR

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six add... [Read more...]

Industry Pharmaceuticals
Founded 1935
CEO Robert Jones
Employees 12
Stock Exchange OTCMKTS
Ticker Symbol ACUR
Full Company Profile

Financial Performance

In 2020, ACUR's revenue was $3.57 million, an increase of 34.36% compared to the previous year's $2.66 million. Losses were -$1.21 million, -67.99% less than in 2019.

Financial Statements

Analyst Forecast

No stock price forecast available yet.

Price Target
n/a
Analyst Consensus: Buy
Stock Forecasts

News

Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03

Amendment Extends NDA Acceptance Date Amendment Extends NDA Acceptance Date

Acura Pharmaceuticals Provides Development Update on LTX-03

PALATINE, Ill., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR) today announced that the LTX-03 (hydrocodone bitartrate and acetaminophen) tablets using Acura's LIMITx techno...

Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results

PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologie...

Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results

PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologie...